Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

By Patrick S L Kwan, A. Arzimanoglou, A. Berg, M. Brodie, W. Allen Hauser, G. Mathern, S. Moshé, E. Perucca, Samuel Wiebe, J. French. Epilepsia, 2009

4,468 citations recorded by the source corpus.

Subfields: Oncology, Pediatrics, Perinatology and Child Health, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/ae11560ac02747b15425fd43c528d9163e6510b1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. Wolfgang Löscher
2. Sanjay M. Sisodiya
3. Heidrun Potschka
4. A. Vezzani

In Pediatrics, Perinatology and Child Health

1. Wolfgang Löscher
2. A. Vezzani
3. Heidrun Potschka

In Psychiatry and Mental health

1. A. Vezzani
2. Heidrun Potschka
3. Wolfgang Löscher

Citations in the corpus

• Trial of Cannabidiol for Drug‐Resistant Seizures in the Dravet Syndrome (2017, neutral): “Vagus­nerve stimulation 6 (10) 9 (15) 15 (12)”
• Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options (2020, background): “An ad hoc Task Force of the International League Against Epilepsy (ILAE) defined drug resistance as “failure of adequate trials of two tolerated, appropriately chosen and used antiepileptic drug schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom” and consider”
• Vagus Nerve Stimulation (2004, neutral): “International League Against Epilepsy (ILAE) A taskforce by the ILAE defines drug resistant epilepsy as a failure of adequate trials of two tolerated, appropriately chosen and used antiepileptic drug schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom (Kwan et”